FOXP1 and estrogen signaling in breast cancer.

Abstract

Breast cancers are considered to be primarily regulated by estrogen signaling pathways because estrogen-dependent proliferation is observed in the majority of breast cancer cases. Thus, hormone therapy using antiestrogen drugs such as tamoxifen is effective for breast cancers expressing estrogen receptor α (ERα). However, acquired resistance during the… (More)
DOI: 10.1016/B978-0-12-416673-8.00006-X

Topics

Cite this paper

@article{Ijichi2013FOXP1AE, title={FOXP1 and estrogen signaling in breast cancer.}, author={Nobuhiro Ijichi and Kazuhiro Ikeda and Kuniko Horie-Inoue and Satoshi Inoue}, journal={Vitamins and hormones}, year={2013}, volume={93}, pages={203-12} }